Page last updated: 2024-11-02

oxotremorine and Asthma

oxotremorine has been researched along with Asthma in 2 studies

Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brantingham, P1
Simson, G1
Bronstein, S1

Trials

2 trials available for oxotremorine and Asthma

ArticleYear
Clinical trial of Theograd.
    The British journal of clinical practice, 1970, Volume: 24, Issue:4

    Topics: Aged; Asthma; Bronchitis; Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Mal

1970
Evaluation of a bronchodilator-expectorant elixir in obstructive pulmonary disease.
    Journal of the American Geriatrics Society, 1966, Volume: 14, Issue:3

    Topics: Adult; Aged; Asthma; Bronchiectasis; Bronchitis; Bronchodilator Agents; Clinical Trials as Topic; Ev

1966